Abstract:Conventionally, immunity in humans has been classified as innate and adaptive, with the concept that only the latter type has an immunological memory/recall response against specific antigens or pathogens. Recently, a new concept of trained immunity (a.k.a. innate memory response) has emerged. According to this concept, innate immune cells can exhibit enhanced responsiveness to subsequent challenges, after initial stimulation with antigen/pathogen. Thus, trained immunity enables the innate immune cells to respond robustly and non-specifically through exposure or re-exposure to antigens/infections or vaccines, providing enhanced resistance to unrelated pathogens or reduced infection severity. For example, individuals vaccinated with BCG to protect against tuberculosis were also protected from malaria and SARS-CoV-2 infections. Epigenetic modifications such as histone acetylation and metabolic reprogramming (e.g. shift towards glycolysis) and their inter-linked regulations are the key factors underpinning the immune activation of trained cells. The integrated metabolic and epigenetic rewiring generates sufficient metabolic intermediates, which is crucial to meet the energy demand required to produce proinflammatory and antimicrobial responses by the trained cells. These factors also determine the efficacy and durability of trained immunity. Importantly, the signaling pathways and regulatory molecules of trained immunity can be harnessed as potential targets for developing novel intervention strategies, such as better vaccines and immunotherapies against infectious (e.g., sepsis) and non-infectious (e.g., cancer) diseases. However, aberrant inflammation caused by inappropriate onset of trained immunity can lead to severe autoimmune pathological consequences, (e.g., systemic sclerosis and granulomatosis). In this review, we provide an overview of conventional innate and adaptive immunity and summarize various mechanistic factors associated with the onset and regulation of trained immunity, focusing on immunologic, metabolic, and epigenetic changes in myeloid cells. This review underscores the transformative potential of trained immunity in immunology, paving the way for developing novel therapeutic strategies for various infectious and non-infectious diseases that leverage innate immune memory.

Trained Innate Immunity in Animal Models of Cardiovascular Diseases

Innate Immune Memory Of Tissue-Resident Macrophages And Trained Innate Immunity: Re-Vamping Vaccine Concept And Strategies

Trained Immunity and Reactivity of Macrophages and Endothelial Cells

Trained immunity in atherosclerotic cardiovascular disease

Innate immune memory in cardiometabolic disease

Trained immunity: adaptation within innate immune mechanisms.

Trained immunity: General and emerging concepts

The future clinical implications of trained immunity

Innate immune memory in the brain shapes neurological disease hallmarks

Innate Immune Memory and the Host Response to Infection

Trained immunity: A link between risk factors and cardiovascular disease

The causes and consequences of trained immunity in myeloid cells

The mechanisms and cross-protection of trained innate immunity

Trained immunity across organs

Metabolic Regulation in the Induction of Trained Immunity

Endotoxin tolerance and trained immunity: breaking down immunological memory barriers

Trained innate immunity: concept, nomenclature and future perspectives

The Role of Cell Metabolism in Innate Immune Memory

Defining trained immunity and its role in health and disease

Trained immunity in type 2 immune responses

Innate Immune Memory in Monocytes and Macrophages: The Potential Therapeutic Strategies for Atherosclerosis